What Has Been the Growth of the Molluscum Contagiosum MC Treatment Market So Far?
The molluscum contagiosum mc treatment market has seen considerable growth due to a variety of factors.
• The market for treatment of molluscum contagiosum (MC) has witnessed substantial growth in the past few years. Its size is estimated to escalate from $2.93 billion in 2024 to $3.11 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 6.2%.
The expansion of this market during the historic period can be traced back to factors such as the soaring awareness about skin infections and their possible treatments, influx in pediatric cases, growth in healthcare expenditure, an increase in the count of immunocompromised individuals, along with increased funding from private entities and government bodies.
What Are the Future Growth Projections for the Molluscum Contagiosum MC Treatment Market?
The molluscum contagiosum mc treatment market is expected to maintain its strong growth trajectory in upcoming years.
• In the years to come, the molluscum contagiosum (MC) treatment market is anticipated to witness substantial growth, with its value predicted to rise to $3.89 billion by 2029, reflecting a compound annual growth rate (CAGR) of 5.8%.
Several drivers can be credited for this anticipated growth in the forthcoming period, including a growing inclination towards non-invasive procedures, rising cases of skin diseases, growing healthcare demand, an increase in chronic disease prevalence, and expanded access to superior treatment alternatives. Notable trends for the forecast period encompass a shift towards cosmetic treatments, progressions in topical delivery systems, a tilt towards home-based treatments, advancements in cryotherapy, and a concentrated focus on pediatric treatment solutions.
What Are The Core Factors Supporting Growth In The Molluscum Contagiosum MC Treatment Market?
The surge in preference for less invasive therapies is anticipated to significantly bolster the expansion of the molluscum contagiosum treatment market. Less invasive therapies are medical procedures that inflict minimal bodily harm, often involving tiny cuts or none at all. The popularity of these therapies stems from their potential to decrease recovery times, reduce surgical risks, and improve patient results compared to conventional procedures. Treatments for molluscum contagiosum utilize less invasive techniques such as cryotherapy and laser therapy, which enable effective removal, expedited recovery, and minimized scarring. Since these therapies usually require fewer appointments, they are particularly effective for treating the commonly extensive lesions in molluscum contagiosum. As an illustration, in 2023, less invasive procedures constituted 83% of all medical procedures, amounting to 35 million procedures, as noted by the American Academy of Facial Plastic and Reconstructive Surgery, a US-based non-profit entity, in February 2024. Meanwhile, traditional surgical procedures comprised the remaining 17%. Hence, the escalating demand for less invasive therapies is triggering the growth of the molluscum contagiosum treatment market.
What Are The Major Segments Within The Global Molluscum Contagiosum MC Treatment Market?
The molluscum contagiosum (MC) treatment market covered in this report is segmented –
1) By Type: Molluscum Contagiosum Virus (MCV) -1, Molluscum Contagiosum Virus (MCV) -2, Molluscum Contagiosum Virus (MCV) -3, Molluscum Contagiosum Virus (MCV) -4
2) By Treatment Type: Topical Therapy, Immune-Modulators And Procedural Treatments
3) By Route Of Administration: Topical, Oral
4) By End User: Hospitals, Dermatology Clinics, Homecare Settings, Other End Users
Subsegments:
1) By Molluscum Contagiosum Virus (MCV) -1: Topical Treatments, Cryotherapy, Curettage
2) By Molluscum Contagiosum Virus (MCV) -2: Topical Treatments, Cryotherapy, Curettage
3) By Molluscum Contagiosum Virus (MCV) -3: Topical Treatments, Cryotherapy, Curettage
4) By Molluscum Contagiosum Virus (MCV) -4: Topical Treatments, Cryotherapy, Curettage
Pre-Book The Molluscum Contagiosum MC Treatment Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are Emerging Trends Reshaping The Dynamics Of The Molluscum Contagiosum MC Treatment Market?
Key players in the molluscum contagiosum (MC) treatment market are prioritizing the development of innovative solutions like topical gels to improve effectiveness, enhance patient adherence, and offer non-invasive treatment methods. Topical gel typically refers to a semi-solid compound applied on the skin or mucous membranes for localized medical treatments. For instance, Ligand Pharmaceuticals Incorporated, a biopharmaceutical firm based in the US, ushered in Pelthos Therapeutics in April 2024 to commercialize Zelsuvmi (brazier) topical gel, 10.3%. This gel, the first FDA-approved at-home therapy for molluscum contagiosum in adults and kids older than one year, delivers nitric oxide to inhibit viral replication, leading to lesion clearance. In comparison to conventional in-office processes like cryotherapy or curettage, Zelsuvmi offers a non-invasive, pain-free choice, hence being a practical and convenient alternative for users aged one year and above.
Who Are the Key Players In The Molluscum Contagiosum MC Treatment Market?
Major companies operating in the molluscum contagiosum (MC) treatment market are:
• Verrica Pharmaceuticals
• Novan Inc.
• Veloce BioPharma LLC
• Gurina Foundation
• Competition Deep Dive
• Azafaros
• Polaryx Therapeutics
• Abbott Medtronic
• Merck & Co.. Inc.
• Pfizer Inc.
• Siemens Healthcare GmbH
• Novartis
• Ligand Pharmaceuticals Incorporated
• Aclaris Therapeutics Inc.
• Verrica Pharmaceuticals Inc.
• Nielsen BioSciences Inc.
• MedCara Pharmaceuticals LLC
• Gurina Foundation
• Veloce BioPharma LLC
• Labo ACM
What Is The Most Dominant Region In The Molluscum Contagiosum MC Treatment Market?
North America was the largest region in the molluscum contagiosum (MC) treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the molluscum contagiosum (MC) treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
